Sanofi (NASDAQ:SNY – Get Free Report) was upgraded by investment analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued on Friday, MarketBeat reports. Other research analysts also recently issued research …